驱虫斑鸠菊对淋巴细胞亚类的影响

探讨驱虫斑鸠菊注射液对小鼠免疫功能的影响,揭示其免疫作用机理。采用流式细胞技术测定驱虫斑鸠菊注射液对小鼠脾脏淋巴细胞亚类表达的影响。结果表明,驱虫斑鸠菊可以增强CD4、CD8、CD3T细胞分化抗原的表达,抑制CD19 B细胞分化抗原的表达;说明驱虫斑鸠菊可增强细胞免疫功能、抑制体液免疫功能。     

利用扁桃斑鸠菊叶发酵生产蛹虫草胞外多糖的条件及其抗氧化活性

蛹虫草胞外多糖具有增强免疫力、抗疲劳等药理活性,有极高的保健价值。为高效地获取蛹虫草胞外多糖,本研究通过向发酵培养基中添加适量的扁桃斑鸠菊叶粉末,来提高蛹虫草发酵液中胞外多糖的产量,并对优化得到的胞外多糖红外吸收光谱和化学抗氧化活性进行了研究。实验结果表明,液体发酵最优条件为:扁桃斑鸠菊叶粉末添加量8 g/L、发酵时间9 d、pH 6.5、接种量5.0 mL,在此条件下,蛹虫草胞外多糖的产量可达(5.24±0.28) mg/mL,与未添加扁桃斑鸠菊叶的空白组相比,胞外多糖产量提高了约205.20%;红外分析与抗氧化活性实验结果显示,扁桃斑鸠菊叶对蛹虫草生产的胞外多糖结构和活性影响较小。该研究结果表明扁桃斑鸠菊叶能够有效地提高蛹虫草胞外多糖的产量,为蛹虫草胞外多糖的高效生产提供了新思路。     

扁桃斑鸠菊抗炎抗氧化作用研究进展

扁桃斑鸠菊Vernonia amygdalina原产非洲热带地区,在当地被广泛用作食物和药物,常用于治疗糖尿病、高血压、发热等多种病症,因其疗效高、安全性好而受到广泛关注。扁桃斑鸠菊具有较强的抗炎和抗氧化作用,通过减轻炎症和氧化应激损伤缓解病症,对多种临床疾病的治疗具有研究和应用价值。本文综述了扁桃斑鸠菊抗炎和抗氧化作用的研究进展,并展望其开发应用前景。     

斑鸠菊饼粕的成分及其利用

斑鸠菊(Vernonia galamensis)种子油富含环氧酸,可作为塑料工业配方。种子提油之后,因富含粗蛋白(43.76％)和碳水化合物(6.57％)而成为极好的牲畜饲料资源。经测试,斑鸠菊种子饼粕的成分如下列各表所示:     

利用扁桃斑鸠菊叶发酵高产粗毛纤孔菌胞外多糖的条件优化及其抗氧化活性研究

粗毛纤孔菌胞外多糖是粗毛纤孔菌液体发酵的重要活性代谢产物,但采用常规的发酵方法,粗毛纤孔菌胞外多糖的产量较低。为更好地获取粗毛纤孔菌胞外多糖,本文采用双向液体发酵的方法,通过向发酵培养基中添加适量的扁桃斑鸠菊叶粉末,来提高粗毛纤孔菌胞外多糖的产量,并对优化得到的胞外多糖抗氧化活性进行了研究。以发酵液中胞外多糖含量为指标,采用单因素实验和正交实验优化发酵条件;采用红外光谱对胞外多糖的结构特征进行分析;通过测定胞外多糖对ABTS、DPPH和羟基自由基的清除率来了解其抗氧化活性。结果表明,最优发酵条件为:扁桃斑鸠菊叶粉末添加量0.5g/L、发酵时间10d、pH 6.5、接种量5.0mL,在此条件下,粗毛纤孔菌胞外多糖的产量达到(2.34±0.25)mg/mL,与未添加扁桃斑鸠菊叶的空白组相比,其胞外多糖产量提高了约216.22%;红外分析与抗氧化活性实验结果表明,添加扁桃斑鸠菊叶后的胞外多糖与未添加扁桃斑鸠菊叶的胞外多糖红外主要吸收峰一致,并且对ABTS、DPPH以及羟基自由基清除能力相近。本研究结果表明扁桃斑鸠菊叶能够有效地提高粗毛纤孔菌胞外多糖的产量,为其他珍稀食药用菌胞外多糖的高效生产提供了新思路。     

驱虫斑鸠菊对B-16黑素瘤细胞酪氨酸酶活性及黑素生成影响

目的 :探讨驱虫斑鸠菊体外对酪氨酸酶活性影响 ,以及对小鼠B - 16黑素瘤细胞株细胞增殖、黑素合成以及细胞内酪氨酸酶的作用。方法 :利用四甲基偶氮唑蓝 (MTT)比色法测定药物对细胞增殖的影响 ;采用酶学方法研究药物对酪氨酸酶活性的影响 ;470nm比色法测定黑素含量。结果驱虫斑鸠菊体外可激活酪氨酸酶活性 ,增强B - 16鼠黑素瘤细胞增殖 ,提高酪氨酸酶和黑色素合成能力 ;对整体动物黑素细胞具有促进合成和分泌作用。结论在白癜风的治疗中 ,驱虫斑鸠菊可增强酪氨酸酶活性 ,进而促进黑素合成     

盆菊矮化栽培技术

针对盆菊株型高、叶茎瘦弱、花朵小、花期短及病虫害严重等方面的技术难题,我们经过六年的摸索和研究,比较系统地掌握了培育“株型矮、茎粗壮、叶片厚绿、花朵大而艳、花期长、病虫为害轻”等盆菊矮化栽培技术。     

驱虫斑鸠菊对小鼠免疫分子的影响

探讨驱虫斑鸠菊对小鼠免疫功能的影响,揭示其免疫作用机理。利用[^3H]-TdR参入法测定驱虫斑鸠菊对小鼠体内免疫功能的影响,运用酶联免疫吸附实验测定驱虫斑鸠菊对小鼠B淋巴细胞分泌抗体功能的影响;采用流式细胞测定方法测定CD19B细胞亚类表达水平;采用[^3H]-TdR参入法利用CTLL－2细胞株测定T淋巴细胞分泌IL－2活性。结果驱虫斑鸠菊的低、中、高三个剂量对体内T、B淋巴细胞的增殖活性、血清总抗体和抗原特异性抗体含量、CD19B细胞亚类表达均有明显的抑制作用,对T淋巴细胞分泌IL－2活性也具有明显抑制作用。说明驱虫斑鸠菊对机体体液免疫和细胞免疫功能都具有明显抑制作用。     

驱虫斑鸠菊对人黑素瘤细胞增殖酪氨酸酶及黑素生成影响的研究

探讨驱虫斑鸠菊对A375人黑素瘤细胞株细胞增殖、黑素合成以及细胞内酪氨酸酶的作用。四甲基偶氮唑蓝（MTT）比色法测定药物对细胞增殖的影响;采用酶学方法研究药物对酪氨酸酶活性的影响;475nm比色法测定黑素含量。结果表明驱虫斑鸠菊可以增强A375人黑素瘤细胞增殖,提高酪氨酸酶和黑色素合成能力。说明驱虫斑鸠菊治疗白癜风是通过增强酪氨酸酶活性及促进黑素合成而发挥作用的。     

三种维药提取物对蛋白酪氨酸磷酸酶1B抑制作用的研究

蛋白酪氨酸磷酸酶1B(PTP1B)是胰岛索增敏的新靶点之一.本文研究了芳香新塔花、沙生蜡菊、驱虫斑鸠菊等3种维药石油醚提取物对PTP1B活性的影响及其对酶的抑制类型.结果表明,所构建的原核表达系统能高表达重组PTP1B(his-PTP1B1-321),分子量为40.8 kDa.3种维药提取物对PTP1B均表现出不同程度...     

New vernocuminosides from the stem barks of Vernonia cumingiana Benth

Seven new stigmastane-type steroidal glycosides, vernocuminosides A-G (1-7), have been isolated from the stem barks of Vernonia cumingiana Benth. The structural elucidation and stereochemistry determination were achieved by spectroscopic and chemical methods including 1D and 2D NMR ((1)H-(1)H COSY, HSQC, HMBC, and NOE) experiments, especially the employment of Snatzke's method expressed by the induced circular dichroism spectra. Anti-inflammatory activities and cytotoxicities of compounds 1-7 were evaluated.     

Chemical Constituents of the Roots of Vernonia cumingiana Benth.

To search for new and bioactive constituents from traditional Chinese medicines, a new steroidal saponin, named vernonioside G （1）, was isolated from the roots of Vernonia cumingiana Benth. （Compositae）. The structure of vernonioside G was elucidated using spectral methods, particularly two-dimensional nuclear magnetic resonance analysis. Together with the new compound, eight known compounds were also isolated and identified from the roots of V. cumingiana, among which, VE-1 （2） and 24-methylenelanost-9（11）- en-3β-ol acetate （3） were assigned NMR data for the first time and compound 3 was obtained as a natural product from a plant for the first time.     

Microbiological transformation of mycophenolic acid

In our microbial screening program, we have isolated a fungal strain which produced mycophenolic acid (MPA). This compound is a selective inhibitor of guanine synthesis and, therefore, it has antibacterial, antiviral, antitumor and selective immunosuppressive activities, too. This last effect was utilised by Roche-Syntex to develop a derivative of MPA to the immunosuppressive drug CellCept®.

In order to obtain novel derivatives of MPA with an enhanced activity, we applied bioconversion of MPA with various microorganisms. TLC with densitometric evaluation and HPLC methods were developed for measurement of MPA derivatives. In the course of the bioconversion of MPA by using various types of microorganisms amidation of the carboxyl group, hydroxylation of the C₄-methyl group and formation of glycoside derivatives from the hydroxyl group located on C₇ were observed as the most frequently occurring transformations. The structures of bioconversion products were determined by UV, IR, ¹H NMR, ¹³C NMR and mass spectroscopic methods.

The taxonomic features of cultures of the species applied in the bioconversion were also determined.     

Six-coordinate phosphorus compounds. Crystal structures and dynamic NMR studies of phosphoranes containing chelating ligands

Hexacoordination of the neutral phosphorus compounds 4–6 is evidenced by their high field ³¹P NMR chemical shifts and is further substantiated by the crystal structure of 5 and 6.5 contains the potentially bis-chelating ligand Ar = (C₆H₃(CH₂NMe₂)₂-2,6) and 6 the same ligand with a protonated amino group. In both cases the compounds exhibit slightly distorted octahedral geometry. In compound 5, only one NMe₂ group is coordinated to the phosphorus atom with an N → P bond of 2.063 Å. In compound 6, the NMe₂ group is coordinated to the phosphorus atom with an N → P bond of 2.007 Å while the dimethylammonium substituent is pointing away from the phosphorus atom forming a hydrogen bridge with two oxygen atoms. The fluxional behavior of these three novel six-coordinate phosphorus compounds was studied by dynamic ¹H NMR spectroscopy.     

Synthesis, platinum(II) complexes and structural aspects of the new tetradentate phosphine cis,trans,cis-1,2,3,4-tetrakis(diphenylphosphino)cyclobutane

Several novel dimers of the composition [M₂Cl₄(trans-dppen)₂] (M=Ni (1), Pd (2), Pt (3)) containing trans-1,2-bis(diphenylphosphino)ethene (trans-dppen) have been prepared and characterized by X-ray diffraction methods, NMR spectroscopy (¹⁹⁵Pt{¹H}, ³¹P{¹H}), elemental analyses, and melting points. The intramolecular [2+2] photocycloaddition of the two diphosphine-bridges in 3 produces [Pt₂Cl₄(dppcb)] (4), where dppcb is the new tetradentate phosphine cis,trans,cis-1,2,3,4-tetrakis(diphenylphosphino)cyclobutane. Neither 1 nor the free diphosphine trans-dppen shows this reaction. In the case of 2 the photocycloaddition is slower than in 3. This difference can be explained by the shorter distance between the two aliphatic double bonds in 3 than in 2, but also different transition probabilities within ground and excited states of the used metals could be involved. Furthermore, variable-temperature ³¹P{¹H} NMR spectroscopy of 2 or 3 reveals a negative activation entropy of 2 for the [2+2] photocycloaddition, but a positive of 3. The removal of chloride from 4 by precipitating AgCl with AgBF₄, and subsequent treatment with 2,2′-bipyridine (bipy) or 1,10-phenanthroline (phen) leads to [Pt₂(dppcb)(bipy)₂](BF₄)₄ (5) and [Pt₂(dppcb)(phen)₂](BF₄)₄ (6), respectively. In an analogous reaction of 4 with PMe₂Ph or PMePh₂, [Pt₂(dppcb)(PMe₂Ph)₄](BF₄)₄ (7) and [Pt₂(dppcb)(PMePh₂)₄](BF₄)₄ (8) are formed. Complexes 1–8 show square–planar coordinations, where the compounds 4–8 have also been characterized by the above mentioned methods together with fast atom bombardment mass spectrometry (7, 8). The crystal structure of 4 reveals two conformations, which arise from an energetic competition between the sterical demands of dppcb and an ideal square–planar environment of Pt(II). The free tetraphosphine dppcb can be obtained easily from 4 by treatment with NaCN. It has been characterized fully by the above methods including ¹³C{¹H} and ¹H NMR spectroscopy. The X-ray structure analysis shows the pure MMMP-enantiomer in the solid crystal, which is therefore optically active. This chirality is induced by a conformation of dppcb, where all four PPh₂ groups are non-equivalent. Variable-temperature ³¹P{¹H} NMR spectroscopy of dppcb confirms this explanation, since the single signal at room temperature is split into two doublets at 183 K. The goal of this article is to demonstrate the facile production of a new tetradentate phosphine from a diphosphine precursor via Pt(II) used as a template.     

Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl] units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding

Two novel dinuclear palladium(II) complexes, {[Pd(en)Cl]₂(bpse)}(NO₃)₂ (1) and {[Pd(en)Cl]₂ (bpsu)}(NO₃)₂ (2), (where en is ethylenediamine; bpse is bis(3-methyl-4-pyridyl) selenide; bpsu is bis(3-methyl-4-pyridyl) sulfide) have been synthesized. The complexes have been characterized by elemental analysis, IR, ¹H NMR, and ¹³C NMR. They have been assayed for antitumor activity in vitro against the mice leukemia L1210 and the human coloadenocarcinoma HCT8 cell lines. The results show that compound 1 has a lower I.D.₅₀ value against the two cancer cell lines as compared to compound 2; the compounds also shows a lower I.D.₅₀ value than cisplatin against the HCT8 cell line, but a higher I.D.₅₀ value than cisplatin against the L1210 cell line. Binding studies indicate that compound 1 possibly interacts with DNA by a nonintercalative mode. Kinetics of binding of the two compounds to DNA are firstly studied using ethidium bromide as a fluorescence probe with stopped-flow spectrophotometer under pseudo-first-order condition. The stronger binding of two steps in the process of the compounds interacting with DNA are observed, and the k_obs and E_a of binding of the two steps (where k_obs is the observed pseudo-first-order rate constant, E_a is the observed energy of activation) are obtained.     

Borane and monoiodoborane derivatives of some bis(diphenylphosphino)alkanes

A series of borane and monoiodoborane derivatives of bis(diphenylphosphino)alkanes. (C₆H₅)₂P--- (CH₂)_n---P(C₆H₅)₂ in which n has values of 2 through 4 has been synthesized. Only compounds with the formulae [(C₆H₅)₂P]₂(CH₂)_n · (BH₃)₂ and (C₆H₅)₂P]₂CH₂)_n · BH₂I were isolable, the latter being boronium iodides. The compounds were characterized by their melting points, elemental analyses, molar conductivities, infrared spectroscopy, and ¹H and ¹¹B nuclear magnetic resonance spectroscopy. The relationship between the length of the carbon chain and the ¹¹B NMR chemical shift is discussed.     

粗枝崖摩中一个新的三萜

从粗枝崖摩(Amoora dasyclada (How et T.Chen)C.Y.Wu)中分离到5个化合物.通过波谱方法鉴定为:24,25-epoxy-tirucall-7-ene-3,23-dione(1),24,25,26,27-tetranortirucall-7-ene-3-oxo-23(21)-lactone(2),taraxerone(3),taraxerol(4)andβ-sitosterol(5).其中化合物1为一个新的三萜,3～5为首次从该植物中分离得到.化合物2是首次从天然植物中分离得到的一个四降三萜,对它的碳谱和氢谱数据进行了全归属.此外化合物2在碳7位上的双键和14位上的甲基并未发生变化,以前文献中没有报道过与此类似的四降三萜,据此进一步讨论了四降三萜的生物合成路径.     

红色红曲霉Mr-1的次级代谢产物生物活性成分分析

【背景】红曲霉(Monascus)是一种重要的药食同源性真菌,其自身产生的次级代谢产物具有多种生理活性功能,然而红曲霉中的生物活性成分却鲜有报道。利用红曲霉发酵液进行药效物质成分追溯,对了解红曲霉药效物质基础具有十分重要的意义。【目的】对红色红曲霉(M.ruber)Mr-1次级代谢产物中的生物活性成分和生物学功能进行研究。【方法】采用硅胶柱、SephadexLH-20凝胶柱等色谱技术对活性成分进行分离纯化,通过核磁共振和高分辨质谱技术对化合物结构进行解析;对鉴定的化合物进行体外抗氧化、抑菌和酶活性测定。【结果】从红色红曲霉Mr-1次级代谢产物中分离得到4个活性化合物,鉴定为3个黄酮类化合物Luteolin(1)、Hesperetin(2)、Glycitein(3)和1个萜类化合物Ursolic acid(4)。化合物1、2、4为首次从红曲菌科中分离得到。在抗氧化试验中,化合物1对ABTS⁺、DPPH和OH^-自由基具有较强的清除能力,IC₅₀分别为13.36、8.74和32.75μg/mL;在抑菌试验中,化合物4对金黄色葡萄球菌(Staphylococcus aureus)和李斯特菌(Listeria monocytogenes)表现出中等强度的抑菌能力,抑菌圈直径分别为13.4 mm和11.9 mm;在α-葡萄糖苷酶抑制活性试验中,化合物4表现出很强的抑制能力,IC₅₀为21.34μg/mL。【结论】红色红曲霉Mr-1是宝贵的微生物种质资源,其产生的次级代谢产物生物活性成分多样,具有开发成功能性食品原料的潜能。     

Chemistry of tris(2,4,6-trimethoxyphenyl)phosphine with rhodium(I) and iridium(I) olefin complexes

Rh(I) and Ir(I) complexes of the type [Rh(cod)(η²-TMPP)]¹⁺ (1) and M(cod)(η²-TMPP-O) (M = Rh (2), Ir (3); cod = cyclooctadiene; TMPP = tris(2,4,6-trimethoxyphenyl)phosphine; TMPP-O = mono-demethylated form of TMPP) have been isolated from reactions of [M(cod)Cl]₂ with M′BF₄ (M′ = Ag⁺, K⁺, Na⁺) followed by addition of the tertiary phosphine ligand. This chemistry is dependent on the identity of the metal, as both the cationic phosphine complex and the neutral phosphino-phenoxide compound are stable for Rh(I), whereas only the latter is stable for Ir(I). The three complexes have been characterized by IR and NMR (¹H and ³¹P) spectroscopies as well as by cyclic voltammetry. The ¹H NMR spectrum of [Rh(cod)(η²-TMPP)]¹⁺ (1) is in accord with the formula and reveals that the TMPP phenyl rings are undergoing rapid exchange between coordinated and non-coordinated modes; the corresponding spectra of 2 and 3 support free rotation about the P---C bonds of the unbound phenyl rings with no fluxionality of the bound demethylated ring. The ³¹P{¹H} NMR spectrum of the neutral species 2 exhibits a significant upfield shift with respect to the analogous cationic compound 1. This shielding is the result of improved electron donation to the metal from a phenoxide group as compared to an ether substituent. In situ addition of CO to the reaction between TMPP and [Rh(cod)Cl]₂ or [Ir(cod)Cl]₂ in the presence of M′BF₄ results in the isolation of the monocarbonyl species [Rh(TMPP)(η²-TMPP)(CO)][BF₄] (5) and the stable dicarbonyl compound [Ir(TMPP)₂(CO)₂][BF₄] (4), respectively. Single crystal X-ray data for

Full-size image

. The geometry of 4 is square planar, with essentially ideal angles for the mutually trans disposed phosphine and carbonyl ligands, as found in earlier studies for the analogous Rh dicarbonyl compound. The ¹H NMR spectrum of 4 supports the assignment of magnetically equivalent phosphorus nuclei in solution. The results of this study indicate that cyclooctadiene is a particularly strong ligand for monovalent late transition metals ligated by TMPP, to the extent that it is inert with respect to substitution in the absence of π-acceptor ligands such as carbon monoxide.